176 related articles for article (PubMed ID: 23593417)
1. Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.
Glesby MJ; Albu J; Chiu YL; Ham K; Engelson E; He Q; Muthukrishnan V; Ginsberg HN; Donovan D; Ernst J; Lesser M; Kotler DP
PLoS One; 2013; 8(4):e61160. PubMed ID: 23593417
[TBL] [Abstract][Full Text] [Related]
2. The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.
Kotler DP; He Q; Engelson ES; Albu JB; Glesby MJ
Antivir Ther; 2016; 21(2):107-16. PubMed ID: 25536669
[TBL] [Abstract][Full Text] [Related]
3. Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation.
Leung V; Chiu YL; Kotler DP; Albu J; Zhu YS; Ham K; Engelson ES; Hammad H; Christos P; Donovan DS; Ginsberg HN; Glesby MJ
HIV Clin Trials; 2016 Mar; 17(2):55-62. PubMed ID: 27077672
[TBL] [Abstract][Full Text] [Related]
4. Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism.
Hansen BR; Haugaard SB; Jensen FK; Jensen JE; Andresen L; Iversen J; Andersen O
HIV Med; 2010 Apr; 11(4):266-75. PubMed ID: 20002779
[TBL] [Abstract][Full Text] [Related]
5. The effect of 30 months of low-dose replacement therapy with recombinant human growth hormone (rhGH) on insulin and C-peptide kinetics, insulin secretion, insulin sensitivity, glucose effectiveness, and body composition in GH-deficient adults.
Rosenfalck AM; Maghsoudi S; Fisker S; Jørgensen JO; Christiansen JS; Hilsted J; Vølund AA; Madsbad S
J Clin Endocrinol Metab; 2000 Nov; 85(11):4173-81. PubMed ID: 11095450
[TBL] [Abstract][Full Text] [Related]
6. Treatment of altered body composition in HIV-associated lipodystrophy: comparison of rosiglitazone, pravastatin, and recombinant human growth hormone.
Macallan DC; Baldwin C; Mandalia S; Pandol-Kaljevic V; Higgins N; Grundy A; Moyle GJ
HIV Clin Trials; 2008; 9(4):254-68. PubMed ID: 18753120
[TBL] [Abstract][Full Text] [Related]
7. Effects of a combination of recombinant human growth hormone with metformin on glucose metabolism and body composition in patients with metabolic syndrome.
Herrmann BL; Berg C; Vogel E; Nowak T; Renzing-Koehler K; Mann K; Saller B
Horm Metab Res; 2004 Jan; 36(1):54-61. PubMed ID: 14983408
[TBL] [Abstract][Full Text] [Related]
8. Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial.
Lo J; You SM; Canavan B; Liebau J; Beltrani G; Koutkia P; Hemphill L; Lee H; Grinspoon S
JAMA; 2008 Aug; 300(5):509-19. PubMed ID: 18677023
[TBL] [Abstract][Full Text] [Related]
9. The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
Lo JC; Mulligan K; Noor MA; Schwarz JM; Halvorsen RA; Grunfeld C; Schambelan M
J Clin Endocrinol Metab; 2001 Aug; 86(8):3480-7. PubMed ID: 11502767
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure.
Johannsson G; Mårin P; Lönn L; Ottosson M; Stenlöf K; Björntorp P; Sjöström L; Bengtsson BA
J Clin Endocrinol Metab; 1997 Mar; 82(3):727-34. PubMed ID: 9062473
[TBL] [Abstract][Full Text] [Related]
11. Effects of GH on body composition and cardiovascular risk markers in young men with abdominal obesity.
Bredella MA; Gerweck AV; Lin E; Landa MG; Torriani M; Schoenfeld DA; Hemphill LC; Miller KK
J Clin Endocrinol Metab; 2013 Sep; 98(9):3864-72. PubMed ID: 23824419
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone in the treatment of HAART-associated lipodystrophy--a randomized double-blind placebo-controlled study.
Sutinen J; Häkkinen AM; Westerbacka J; Seppälä-Lindroos A; Vehkavaara S; Halavaara J; Järvinen A; Ristola M; Yki-Järvinen H
Antivir Ther; 2003 Jun; 8(3):199-207. PubMed ID: 12924536
[TBL] [Abstract][Full Text] [Related]
13. Improved insulin sensitivity and body fat distribution in HIV-infected patients treated with rosiglitazone: a pilot study.
Gelato MC; Mynarcik DC; Quick JL; Steigbigel RT; Fuhrer J; Brathwaite CE; Brebbia JS; Wax MR; McNurlan MA
J Acquir Immune Defic Syndr; 2002 Oct; 31(2):163-70. PubMed ID: 12394794
[TBL] [Abstract][Full Text] [Related]
14. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
15. Comparison of rosiglitazone and metformin for treating HIV lipodystrophy: a randomized trial.
van Wijk JP; de Koning EJ; Cabezas MC; op't Roodt J; Joven J; Rabelink TJ; Hoepelman AI
Ann Intern Med; 2005 Sep; 143(5):337-46. PubMed ID: 16144892
[TBL] [Abstract][Full Text] [Related]
16. Short-term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity: a randomized, double-blind, placebo-controlled, crossover study.
Gravholt CH; Naeraa RW; Brixen K; Kastrup KW; Mosekilde L; Jørgensen JO; Christiansen JS
Pediatrics; 2002 Nov; 110(5):889-96. PubMed ID: 12415026
[TBL] [Abstract][Full Text] [Related]
17. Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection.
Engelson ES; Glesby MJ; Mendez D; Albu JB; Wang J; Heymsfield SB; Kotler DP
J Acquir Immune Defic Syndr; 2002 Aug; 30(4):379-91. PubMed ID: 12138344
[TBL] [Abstract][Full Text] [Related]
18. Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio.
Mulligan K; Yang Y; Wininger DA; Koletar SL; Parker RA; Alston-Smith BL; Schouten JT; Fielding RA; Basar MT; Grinspoon S
AIDS; 2007 Jan; 21(1):47-57. PubMed ID: 17148967
[TBL] [Abstract][Full Text] [Related]
19. A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy.
Blümer RM; van der Valk M; Ackermans M; Endert E; Serlie MJ; Reiss P; Sauerwein HP
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1097-104. PubMed ID: 19690066
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial.
Waters D; Danska J; Hardy K; Koster F; Qualls C; Nickell D; Nightingale S; Gesundheit N; Watson D; Schade D
Ann Intern Med; 1996 Dec; 125(11):865-72. PubMed ID: 8967666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
